Effects of protein tyrosine kinase inhibitors on the replication of herpes simplex virus and the phosphorylation of viral proteins

Intervirology

Volumn 40, Issue 1, 1997, Pages 7-14

  Yura, Y ^a   Kusaka, J ^a   Tsujimoto, H ^a   Yoshioka, Y ^a   Yoshida, H ^a   Sato, M ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Herbimycin A; Herpes simplex virus; Tyrphostin; UL47 gene products

Indexed keywords

3,5 DI TERT BUTYL 4 HYDROXYBENZYLIDENEMALONONITRILE; AG 213; AG 555; HERBIMYCIN A; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN TYROSINE KINASE INHIBITOR; TYRPHOSTIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; AUTOPHOSPHORYLATION; CONTROLLED STUDY; HERPES; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; VERO CELL; VIRUS PLAQUE; VIRUS REPLICATION; VIRUS TITRATION;

ANIMALIA; HERPES; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 0030843760     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000150515     Document Type: Article

References (34)

1. Hunter T, Cooper JA: Protein-tyrosine kinases, Annu Rev Biochcm 1985:54:897-930.
2. Ullrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity, Cell 1990:61:203-212.
3. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s, Nature 1993:362: 801-809.
4. Elder JT, Fisher CJJ, Lindquist PB, Bennett GL, Pittclkovv MR, Coffey RJ Jr, Ellingsworth L, Derynck R, Voorhccs JJ: Ovcrcxpression of transforming growth factor a in psoriatic epidermis, Science 1989:243:811-814.
5. Dong Z, Qi X, Fidler H: Tyrosine phosphorylation of mitogen-activated protein kinases is necessary for activation of murine macrophages by natural and synthetic bacterial products, J Exp Med 1993:177:1071-1077.
6. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Walanabe S, Itoh N, Shibuya M, Fukami Y: Genistein, a specific inhibitor of tyrosine-specific protein kinases, J Biol Chem 1987:262: 5592-5595.
7. Uehara Y, Murakami Y, Sugimoto Y, Mizuno S: Mechanism of reversion of Rous sarcoma virus transformation by herbimycin A: Reduction of total phosphotyrosine levels due to reduced kinase activity and increased turnover of p60, Cancer Res 1989:49:780-785.
8. Yoneda T, Lvall RM, Alsina MM, Persons PE, Spada AP, Levitzki A, Zilbcrstein A, Mundy GR: The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice, Cancer Res 1991:51:4430-4435.
9. Kaur G, Gazit A, Levitzki A, Stowe E, Cooney DA, Sausville EA: Tyrphoslin induced growth inhibition: Correlation with effect on p2lbcr-abl autokinase activity in K562 chronic myelogenous leukemia, Anticanccr Drugs 1994:5: 213-222.
10. Sion Vardv N, Vardy D, Rodeck U, Kari C, Levin RM, Malkowicz SB: Antiproliferative effects of tyrosine kinase inhibitors (tyrphostins) on human bladder and renal carcinoma cells, J SurgRes 1995:59:675-680.
11. Ben Bassat H, Vardi DV, Gazit A, Klaus SN, Chaouat M, Hartzstark Z, Levitzki A: Tyrphostins suppress the growth of psoriatic kératinocytes, Exp Dermatol 1995:4:82-88.
12. Yaish P, Gazil A, Gilon C, Levitzki A: Blocking of EGF-dcpendcnt cell proliferation by EGF receptor kinase inhibitors, Science 1988: 242:933-935.
13. Bilder GE, Krawiec JA, McVety K, Gazit A, Gilon C, Lyall R, Zilbcrstein A, Levitzki A, Pcrrone MH, Schreiber AB: Tyrphostins inhibit PDGF-induccd DNA synthesis and associated early events in smooth muscle cells, Am J Physiol 1991;260:C721-C730.
14. bcrabl tyrosine kinase activity induces K562 to differentiate, Blood 1993:82:3524- 3529.
15. Esther A, lftach S, Esther P: Inhibition of Moloney murine leukemia virus replication by tyrphostins, tyrosine kinase inhibitors, FEBS Lett 1994:341:99-103.
16. Yura Y, Kusaka J, Kondo Y, Tsujimoto H, Yoshida H, Sato M: Inhibitory effect of tyr-phostin on the replication of herpes simplex virus type 1, Arch Virol 1995:140:1181-1194.
17. Cohen DI, Tani Y, Tian H, Boone E, Samelson LE, Lane HC: Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1, Science 1992:256: 542-545.
18. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxity assays, J Immun Methods 1983:65:55-63.
19. Wilcox KW, Kohn A, Sklyanskaya E, Roizman B: Herpes simplex virus phosphoproteins, I, Phosphate cycles on and off some viral polypeptides and can alter their affinity for DNA, J Virol 1980:33:167-182.
20. Lemaster S, Roizman B: Herpes simplex virus phosphoproteins, II, Characterization of the virion protein kinase and of the polypeptides phosphorylated in the virion, J Virol 1980:35: 798-811
21. McKnighl JLC, Pcllctt PE, Jenkins F, Roizman B: Characterization and nucleotide sequence of two herpes simplex virus I genes whose products modulate a-trans-inducing factor-dependent activation of a genes, J Virol 1987:61: 992-1001.
22. Liu F-T, Zinneckcr M, Hamaoka T, Katz DH: New procedures for preparation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates, Biochemistry 1979: 18:690-697.
23. Imajoh-Ohmi S, Tokita K, Ochiai H, Nakamura M, Kanegasaki S: Topology of cytochrome B558 in neutrophil membrane analyzed by anti-peptide antibodies and proteolysis, J Biol Chem 1992:267:180-184.
24. Yura Y, Yoshida H, Sato M: Inhibition of herpes simplex virus replication by genistein, an inhibitor of protein-tyrosine kinase, Arch Virol 1993:132:451-461.
25. Levitzki A, Gazil A: Tyrosine kinase inhibition: An approach to drug development, Science 1995:267:1782-1788.
26. Levitzki A, Gazit A, Osherov N, Posner I, Gilon C: Inhibition of protein-tyrosine kinases by tyrphostins, Methods Enzymol 1991:201: 347-361.
27. McLean G, Rixon F, Langeland N, Haarr L, Marsden H: Identification and characterization of the virion protein products of herpes simplex virus type 1 gene UL47, J Gen Virol 1990;71:2953-2960.
28. McGoch DJ, Dalrymple MA, Davison AJ, Dolan A, Frame MC, McNab D, Perry LJ, Scott JE, Taylor P: The complete DNA sequence of the long unique region in the genome of herpes simplex virus type I, J Gen Virol 1988:69: 1531-1574.
29. Zharg Y, McKnight JLC: Herpes simplex virus type I UL46 and UL47 deletion mutants lack VPU and VP12 or VP13 and VP14, respectively, and exhibit altered viral thymidine kinase expression, J Virol 1993:67:1482- 1492.
30. Miller CL, Lee JH, Kiel TE, Burkhardt AL, Bolen JB, Longneckcr R: Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in slg-mcdiatcd signal transduction, Infect Agents Dis 1994;3:128-136.
31. Yamada Y, Yamamoto N, Maeno K, Nishiya-ma Y: Role of DNA topoisomcrasc I in the replication of herpes simplex virustypc 2, Arch Viroi 1990:110:121-127.
32. Purves FC, Katan M, Stevcly WS, Leader DP: Characteristics of the induction of a new protein kinase in cells infected with herpesviruses, J Gen Virol 1986;67:1049-1057.
33. Purves FC, Spcctor D, Roizman B: The herpes simplex virus 1 protein kinase encoded by the Us3 gene mediates posttranslational modification of the phosphoprotein encoded by the Ui.34gene, J Virol 1991;65:5757-5764.
34. Cunningham C, Davison AJ, Dolan A, Frame MC, McGeoch DJ, Meredith DM, Moss HWM, Orr AC: The UL13 virion protein of herpes simplex virus type I is phosphorylated by a novel virus-induced protein kinase, J Gen Virol 1992:73:303-311.